The popularity of copyright’s blockbuster initially drove a surge for pharma, but recent changes present a murky picture for investors. Lower-cost alternatives are eroding revenue, and persistent legal battles add https://brendagzvl601892.techionblog.com/41423660/sildenafil-and-big-pharma-a-volatile-play